Infection and Drug Resistance
Volume 12, 2019 - Issue
Open access
209
Views
3
CrossRef citations to date
0
Altmetric
Original Research
Cefuroxime compared to piperacillin/tazobactam as empirical treatment of Escherichia coli bacteremia in a low Extended-spectrum beta-lactamase (ESBL) prevalence cohort
Sara Thønnings1 Department of Clinical Microbiology, Copenhagen University Hospital, Hvidovre, Denmark;2 Toxicology Laboratory, Analytical BioSciences, Department of Pharmacy, University of Copenhagen, Copenhagen, DenmarkCorrespondence[email protected]
, Filip Jansåker1 Department of Clinical Microbiology, Copenhagen University Hospital, Hvidovre, Denmark;3 Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
, Kim Oren Gradel4 Center for Clinical Epidemiology, Odense University Hospital, Odense, Denmark;5 Research Unit of Clinical Epidemiology, Institute of Clinical Research, University of Southern Denmark, Odense, Denmark
, Bjarne Styrishave2 Toxicology Laboratory, Analytical BioSciences, Department of Pharmacy, University of Copenhagen, Copenhagen, Denmark
& Jenny Dahl Knudsen1 Department of Clinical Microbiology, Copenhagen University Hospital, Hvidovre, Denmark
Pages 1257-1264
|
Published online: 13 May 2019
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.